Asthma guidance welcomed5th December 2007
Drug manufacturer GlaxoSmithKline has welcomed guidance issued by the National Institute of Health and Clinical Excellence (NICE) on chronic asthmas in children under 12 years old.
The guidance recommends combination treatments such as Seretide®* (salmeterol/fluticasone propionate) as an option for children, needing both an inhaled corticosteroid (ICS) and a long-acting beta2 agonist (LABA) to control their asthma. The guidance gives healthcare professionals the freedom to choose between a combination treatment or separate devices for ICS. About one million children in the UK are known to have asthma.
Share this page
There are no comments for this article, be the first to comment!
Post your comment
Only registered users can comment. Fill in your e-mail address for quick registration.
Title: Asthma guidance welcomed
Author: Mark Nicholls
Article Id: 4994
Date Added: 5th Dec 2007